Total funding in the Indian health-tech sector witnessed a 55% plunge from $3.2 billion in 2021 to $1.4 billion in 2022, as investors across the globe become more cautious amid the current macroeconomic conditions, and rising interest rates, according to a report by market intelligence platform Tracxn.

However, despite the sharp decrease in investments witnessed in the year, it is still the second-highest funded year in the past decade, after 2021 when the health tech sector enjoyed a positive investor sentiment due to the Covid pandemic.

According to the report, only two $100 million+ funding rounds took place in 2022, compared with 10 during the previous year; Digital healthcare platform MediBuddy's $125 million in a Series C funding round from Quadria Capital and others and Consumer nutrition platform HealthKart's $135 million Series H round from Temasek and others.

This post is for subscribers only

Sign up to read the post and as well as all other member only posts. Subscribing only takes a few seconds and will give you immediate access.
Subscribe now